January 07, 2026-- NeuraLight, the leader in developing precision biomarkers for neurology, today announced the completion of PALOMA, a pioneering study comparing eye-movement measures with standard ...
PALOMA study is one of the largest longitudinal studies using eye-movement biomarkers in patients with Parkinson’s diseaseNEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--NeuraLight, the leader in ...
Cell and gene therapies use the body's building blocks - cells and genetic material - to boost the immune system or correct ...
Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...
Jesy Nelson noticed worrying signs about her twin daughters’ Ocean Jade and Story Monroe’s health, weeks before they were ...
Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...
Patients who experience adverse ocular effects with bisphosphonates have a notably higher risk for osteonecrosis than those who do not experience such events, a large cohort study shows.
Three-Way Collaboration to Bring Innovative Oral Mucosal Stem Cell Therapy with U.S. GMP Manufacturing and Commercialization ...
MedPage Today on MSN
Eye Issues Common With ANCA-Associated Vasculitis
Conjunctivitis or episcleritis and scleritis comprised the most common eye manifestations, while cataracts (11.7%) and visual ...
FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment SHANGHAI and ATLANTA and NEW HAVEN, Conn., Jan. 05, 2026 (GLOBE ...
Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time. This advancement opens new possibilities for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback